- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04955457
BDNF Promoter Methylation: Effects on Cognition, Stress and Anxiety and Depression Symptom in Healthy Women. (BDNFm)
July 7, 2021 updated by: Ana Flávia Marçal Pessoa
The purpose of this study is to explore the association between BDNF methylation and neurocognitive performance, perceived stress, and well-being in healthy women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
WI
-
Sao Paulo, WI, Brazil, 53703
- Universidade Federal de Sao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
23 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Female participants will be recruited from public schools linked to the "Diretoria Regional de Educação de Santo Amaro - DRESA" - a southern section of the São Paulo City Hall public education secretaryship.
Description
Inclusion Criteria: (1)Brazilian female aged between 23 and 65 years and (2) currently working in the classroom
Exclusion Criteria:
- diagnosis of depression
- diagnosis of anxiety disorder
- diagnosis of squizofrenia
- report of an infectious condition in the last 15 days before collecting a blood sample;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Explore BDNF methylation level in healthy women active teachers
Time Frame: baseline
|
Venous blood was obtained from all participants to DNA extraction and BDNF methylation analyses.
|
baseline
|
|
Explore episodic memory in healthy women active teachers
Time Frame: Baseline
|
The RAVLT is a validated neuropsychologic test to evaluate learning and memory (episodic memory)an assessment of verbal learning over 5 trials and 30-minute delayed free recall
|
Baseline
|
|
Explore working memory in healthy women active teachers
Time Frame: Baseline
|
Investigates the capacity of working memory (auditory) and attention.
It consists of two tables with different numbers, one with a direct order and another with a reverse order.
The sequence of numbers is read aloud to the participant, one by one, where he must immediately repeat them to the examiner.
The same happens with numbers in reverse order, but the participant must repeat the numbers backwards (reverse order).
The maximum possible score to be reached in the forward order is 16 points, and in the reverse order 14 points totaling 30 points in the total score.
For evaluation, the result must be compared with the standardization according to age.
|
Baseline
|
|
Explore attention in healthy women active teachers
Time Frame: Baseline
|
Trail Making Test (TMT): is used to assess divided attention, consisting of two parts (A and B).
It also assesses motor function, mental flexibility, visual processing speed and aspects of sustained and alternating attention.
In both parts, the participant must draw a path marked by numbers in the shortest time possible and without taking the pencil off the paper.
In part A, you must draw a path marked by numbers in ascending order, from 1 to 25.
Part B has a higher degree of difficulty, requiring greater cognitive demand from the participant, who must draw the path, now marked with numbers ranging from 1 to 13, alternating with letters, ranging from A to L, thus: 1-A-2-B-3-C...
And so on.
The score is measured by the total time the participant took to perform each task and compared with the standardization for their age group.
|
Baseline
|
|
Explore selective attention in healthy women active teachers
Time Frame: Baseline
|
• Stroop Test: Allows you to detect neurological and brain problems and is also used to check and measure levels of concentration and cognitive functions, selective attention and speed of processing information.
The test must be applied to adults over 25 years of age and consists of three tasks: the first in reading words, the second in naming colors, and the third in identifying and naming the color of each word that is written in distinct colors from its nomenclature, which is called the interference effect (or stroop effect).
The score is obtained by scoring total correct answers in each of these tasks, and compared with the current standardization.
|
Baseline
|
|
Explore perceived stress in healthy women active teachers
Time Frame: Baseline
|
Perceived Stress Scale (PSS): is used to assess the individual's perception of stress (subjective stress assessment), where it should be noted how uncontrollable and unpredictable the events of their life experienced in the last month seem to be.
The test consists of 10 items, 6 of positive aspects and 4 of negative aspects, and must be answered within a Likert-type frequency scale (ranging from 0 - Never to 4-Always).
For its evaluation, all the answers must be added together to obtain a total perceived stress score, which must be compared with the standardization of the test for the equivalent population
|
Baseline
|
|
Explore resilience in healthy women active teachers
Time Frame: Baseline
|
• Connor-Davidson Resilience Scale (CD-RISC): a 25-item scale divided into 5 factors, namely: personal competence, confidence in one's instincts, positive acceptance of change, tolerance in the face of adversity, control and spirituality.
The scale is self-applicable and the participant must mark answers ranging from 0 (never true) to 4 (always true).
The result is obtained through the sum of the total score, which can range from 0 to 40 points, where the higher the score, the greater the participant's degree of resilience.
|
Baseline
|
|
Explore psychological well-being in healthy women active teachers
Time Frame: Baseline
|
• Psychological Well-Being Scale (PWBS): the scale consists of 84 items, subdivided into 6 scales that assess the dimensions of psychological well-being, with 14 items each.
The answers are obtained through a Likert-type scale, ranging from 0 (totally disagree) to 6 (totally agree).
The subscales are divided as follows: Self-acceptance, Positive relationship with others, autonomy, mastery of the environment, purpose in life and personal growth.
The result is obtained through the sum of the items of each subscale, and the higher the score, the better the levels of psychological well-being according to each subscale.
|
Baseline
|
|
Explore positive and negative affect in healthy women active teachers
Time Frame: Baseline
|
• Positive and negative affect scale (PANAS): Aims to identify the dimensions of affect of subjective well-being, through 20 items provided, where participants must indicate how they have been feeling lately.
These items are distributed into 10 of subjective emotions that comprise negative affects, and 10 items that comprise positive affects, being issued on a 5-point Likert scale ranging from 1 (not at all) to 5 (extremely).
|
Baseline
|
|
Explore anxiety and depression symptoms in healthy women active teachers
Time Frame: Baseline
|
• Hospital Anxiety and Depression Scale (HADS): It was developed to identify probable and possible levels and cases of Anxiety and Depression in clinical and non-clinical populations.
It consists of 14 items divided into two subscales of 7 items each, where one comprises questions to identify signs of anxiety disorders, and the other of depression.
The answers range from 0 to 3 points, ranging from absent to very frequent, with a maximum score of 21 points.
The cutoff point obtained in the literature for both subscales is ≥ 9 points
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniela Rodrigues de Oliveira, PhD, Federal University of São Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2018
Primary Completion (ACTUAL)
June 1, 2019
Study Completion (ACTUAL)
June 1, 2019
Study Registration Dates
First Submitted
June 21, 2021
First Submitted That Met QC Criteria
July 7, 2021
First Posted (ACTUAL)
July 8, 2021
Study Record Updates
Last Update Posted (ACTUAL)
July 13, 2021
Last Update Submitted That Met QC Criteria
July 7, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3.159.669/2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.